Scribe Therapeutics Inc.
Research Scribe Therapeutics Inc. (SCTX) on Bullrun: market cap USD 380.15M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSCTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 380.15M
- Financial periodQ2 2026
- RevenueUSD 1.92M
- Net income-USD 6.48M
- Free cash flow-USD 5.35M
Valuation Snapshot
latest market cap is USD 380.15M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 51.17M | -USD 21.81M | -USD 46.48M | n/a | n/a | USD 12.80M | USD 41.43M | -USD 143.42M |
| FY2024 | USD 27.41M | -USD 47.79M | -USD 46.58M | n/a | n/a | USD 12.60M | USD 41.68M | -USD 125.86M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 380.15M | n/a | n/a | n/a |
About Scribe Therapeutics Inc.
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a);
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scribe Therapeutics Inc.'s market cap?
Scribe Therapeutics Inc.'s market capitalization is USD 380.15M.
What does Scribe Therapeutics Inc. do?
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States.